-
1
-
-
84864446464
-
How I, treat CML blast crisis
-
1:CAS:528:DC%2BC38XhtFOgur3L 22653972 doi:10.1182/blood-2012-03-380147
-
Hehlmann R. How I, treat CML blast crisis. Blood. 2012;120(4):737-47. doi:10.1182/blood-2012-03-380147.
-
(2012)
Blood
, vol.120
, Issue.4
, pp. 737-747
-
-
Hehlmann, R.1
-
2
-
-
61849163272
-
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
-
3952549 1:CAS:528:DC%2BD1MXisV2iurs%3D 18827185 doi:10.1182/blood-2008-03-144790
-
Quintas-Cardama A, Cortes J. Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2009;113(8):1619-30. doi:10.1182/blood-2008-03-144790.
-
(2009)
Blood
, vol.113
, Issue.8
, pp. 1619-1630
-
-
Quintas-Cardama, A.1
Cortes, J.2
-
3
-
-
84862763893
-
Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population
-
22349721 doi:10.1007/s00277-012-1421-6
-
Mu Q, Ma Q, Wang Y, Chen Z, Tong X, Chen FF, et al. Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population. Ann Hematol. 2012;91(7):1065-72. doi:10.1007/s00277-012-1421-6.
-
(2012)
Ann Hematol
, vol.91
, Issue.7
, pp. 1065-1072
-
-
Mu, Q.1
Ma, Q.2
Wang, Y.3
Chen, Z.4
Tong, X.5
Chen, F.F.6
-
4
-
-
77949423503
-
Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment
-
1:STN:280:DC%2BC3c7mvVWmtg%3D%3D 19865111 doi:10.1038/leu.2009.222
-
Haferlach C, Bacher U, Schnittger S, Weiss T, Kern W, Haferlach T. Similar patterns of chromosome abnormalities in CML occur in addition to the Philadelphia chromosome with or without tyrosine kinase inhibitor treatment. Leukemia. 2010;24(3):638-40. doi:10.1038/leu.2009.222.
-
(2010)
Leukemia
, vol.24
, Issue.3
, pp. 638-640
-
-
Haferlach, C.1
Bacher, U.2
Schnittger, S.3
Weiss, T.4
Kern, W.5
Haferlach, T.6
-
5
-
-
84927558221
-
Previously unreported chromosomal aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a patient with accelerated phase Ph + CML
-
3965933 24711936 doi:10.1155/2014/582016
-
Aydin C, Cetin Z, Salim O, Yucel OK, Undar L, Berker KS. Previously unreported chromosomal aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a patient with accelerated phase Ph+CML. Case reports in genetics. 2014;2014:582016. doi:10.1155/2014/582016.
-
(2014)
Case Reports in Genetics
, vol.2014
, pp. 582016
-
-
Aydin, C.1
Cetin, Z.2
Salim, O.3
Yucel, O.K.4
Undar, L.5
Berker, K.S.6
-
6
-
-
0026498360
-
t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia
-
1:STN:280:DyaK3s%2Fks1SksQ%3D%3D 1423224
-
Dastugue N, Duchayne E, Huguet F, Demur C, Plaisancie H, Calvas P, et al. t(9;11)(p22;q23) translocation in blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet. 1992;63(1):37-42.
-
(1992)
Cancer Genet Cytogenet
, vol.63
, Issue.1
, pp. 37-42
-
-
Dastugue, N.1
Duchayne, E.2
Huguet, F.3
Demur, C.4
Plaisancie, H.5
Calvas, P.6
-
7
-
-
0025374198
-
Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia
-
1:STN:280:DyaK3c3jsF2nsw%3D%3D 2332039
-
Haus O, Noworolska A, Laskowski M, Kuliszkiewicz-Janus M, Kozlowska J, Harlozinska-Szmyrka A, et al. Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia. Exp Mol Pathol. 1990;52(2):235-42.
-
(1990)
Exp Mol Pathol
, vol.52
, Issue.2
, pp. 235-242
-
-
Haus, O.1
Noworolska, A.2
Laskowski, M.3
Kuliszkiewicz-Janus, M.4
Kozlowska, J.5
Harlozinska-Szmyrka, A.6
-
8
-
-
0027197926
-
Blastic phase chronic myeloid leukemia with a four-break rearrangement: T(11;9)(9;22)(q23;p22q34;q11)
-
1:STN:280:DyaK3szlvVarsw%3D%3D 8353804
-
Li L, Ritterbach J, Harbott J, Schroyens W, Lohmeyer J, Pralle H, et al. Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11). Cancer Genet Cytogenet. 1993;68(2):131-4.
-
(1993)
Cancer Genet Cytogenet
, vol.68
, Issue.2
, pp. 131-134
-
-
Li, L.1
Ritterbach, J.2
Harbott, J.3
Schroyens, W.4
Lohmeyer, J.5
Pralle, H.6
-
9
-
-
0035305436
-
Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia
-
1:CAS:528:DC%2BD3MXjtlegsLc%3D 11343772
-
Nishii K, Usui E, Sakakura M, Miyata E, Ridge SA, Ford AM, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigen-expressing leukemia. Cancer Genet Cytogenet. 2001;126(1):8-12.
-
(2001)
Cancer Genet Cytogenet
, vol.126
, Issue.1
, pp. 8-12
-
-
Nishii, K.1
Usui, E.2
Sakakura, M.3
Miyata, E.4
Ridge, S.A.5
Ford, A.M.6
-
10
-
-
34447309617
-
Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia
-
17608714 doi:10.1111/j.1600-0609.2007.00884.x
-
Otero L, Moellmann AC, Pombo-de-Oliveira MS, Ornellas MH, Pires V, Bouzas LF, et al. Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia. Eur J Haematol. 2007;79(2):179-81. doi:10.1111/j.1600-0609.2007.00884.x.
-
(2007)
Eur J Haematol
, vol.79
, Issue.2
, pp. 179-181
-
-
Otero, L.1
Moellmann, A.C.2
Pombo-De-Oliveira, M.S.3
Ornellas, M.H.4
Pires, V.5
Bouzas, L.F.6
-
11
-
-
0032883701
-
Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients
-
1:CAS:528:DyaK1MXmsVWgsbo%3D 10526539
-
Rajcan-Separovic E, Bence-Bruckler I, Wells P, Wang H. Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients. Cancer Genet Cytogenet. 1999;114(1):71-4.
-
(1999)
Cancer Genet Cytogenet
, vol.114
, Issue.1
, pp. 71-74
-
-
Rajcan-Separovic, E.1
Bence-Bruckler, I.2
Wells, P.3
Wang, H.4
-
12
-
-
0037396630
-
Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment
-
1:STN:280:DC%2BD3s7msVyqtA%3D%3D 12682644 doi:10.1038/sj.leu.2402877
-
Royer-Pokora B, Hildebrandt B, Redmann A, Herold C, Kronenwett R, Haas R, et al. Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment. Leukemia. 2003;17(4):807-10. doi:10.1038/sj.leu.2402877.
-
(2003)
Leukemia
, vol.17
, Issue.4
, pp. 807-810
-
-
Royer-Pokora, B.1
Hildebrandt, B.2
Redmann, A.3
Herold, C.4
Kronenwett, R.5
Haas, R.6
-
13
-
-
1842610783
-
Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia
-
1:CAS:528:DC%2BD2cXivVWmtr8%3D 15066325 doi:10.1016/j.cancergencyto.2003.09.005
-
Suzuki K, Sugawara T, Kowata S, Utsugizawa T, Ito S, Murai K, et al. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet. 2004;150(2):159-63. doi:10.1016/j.cancergencyto.2003.09.005.
-
(2004)
Cancer Genet Cytogenet
, vol.150
, Issue.2
, pp. 159-163
-
-
Suzuki, K.1
Sugawara, T.2
Kowata, S.3
Utsugizawa, T.4
Ito, S.5
Murai, K.6
-
14
-
-
80052683427
-
Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
-
3238483 22184534
-
Zamecnikova A. Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib. Hematology reports. 2011;3(2):e13.
-
(2011)
Hematology Reports
, vol.3
, Issue.2
, pp. e13
-
-
Zamecnikova, A.1
-
15
-
-
27244440324
-
Molecular genetics of acute lymphoblastic leukemia
-
1:CAS:528:DC%2BD2MXhtFWntbnN 16155013 doi:10.1200/JCO.2005.05.047
-
Armstrong SA, Look AT. Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol. 2005;23(26):6306-15. doi:10.1200/JCO.2005.05.047.
-
(2005)
J Clin Oncol
, vol.23
, Issue.26
, pp. 6306-6315
-
-
Armstrong, S.A.1
Look, A.T.2
-
16
-
-
35548995884
-
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: A final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group
-
1:CAS:528:DC%2BD2sXht1WgsbnI 17690691 doi:10.1038/sj.leu.2404903
-
Tomizawa D, Koh K, Sato T, Kinukawa N, Morimoto A, Isoyama K, et al. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group. Leukemia. 2007;21(11):2258-63. doi:10.1038/sj.leu.2404903.
-
(2007)
Leukemia
, vol.21
, Issue.11
, pp. 2258-2263
-
-
Tomizawa, D.1
Koh, K.2
Sato, T.3
Kinukawa, N.4
Morimoto, A.5
Isoyama, K.6
-
17
-
-
0141816710
-
AML with 11q23/MLL abnormalities as defined by the WHO classification: Incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases
-
1:CAS:528:DC%2BD3sXnslyktL4%3D 12805060 doi:10.1182/blood-2003-02-0434
-
Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood. 2003;102(7):2395-402. doi:10.1182/blood-2003-02-0434.
-
(2003)
Blood
, vol.102
, Issue.7
, pp. 2395-2402
-
-
Schoch, C.1
Schnittger, S.2
Klaus, M.3
Kern, W.4
Hiddemann, W.5
Haferlach, T.6
-
18
-
-
84887320453
-
The MLL recombinome of acute leukemias in 2013
-
3826032 1:CAS:528:DC%2BC3sXhslaqs73M 23628958 doi:10.1038/leu.2013.135
-
Meyer C, Hofmann J, Burmeister T, Groger D, Park TS, Emerenciano M, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013;27(11):2165-76. doi:10.1038/leu.2013.135.
-
(2013)
Leukemia
, vol.27
, Issue.11
, pp. 2165-2176
-
-
Meyer, C.1
Hofmann, J.2
Burmeister, T.3
Groger, D.4
Park, T.S.5
Emerenciano, M.6
-
19
-
-
0037328737
-
Transcriptional activation is a key function encoded by MLL fusion partners
-
1:CAS:528:DC%2BD3sXht1GltLg%3D 12592336 doi:10.1038/sj.leu.2402804
-
Zeisig BB, Schreiner S, Garcia-Cuellar MP, Slany RK. Transcriptional activation is a key function encoded by MLL fusion partners. Leukemia. 2003;17(2):359-65. doi:10.1038/sj.leu.2402804.
-
(2003)
Leukemia
, vol.17
, Issue.2
, pp. 359-365
-
-
Zeisig, B.B.1
Schreiner, S.2
Garcia-Cuellar, M.P.3
Slany, R.K.4
-
20
-
-
67650770689
-
The molecular biology of mixed lineage leukemia
-
2704309 1:CAS:528:DC%2BD1MXhtVGitrrK 19535349 doi:10.3324/haematol.2008.002436
-
Slany RK. The molecular biology of mixed lineage leukemia. Haematologica. 2009;94(7):984-93. doi:10.3324/haematol.2008.002436.
-
(2009)
Haematologica
, vol.94
, Issue.7
, pp. 984-993
-
-
Slany, R.K.1
-
21
-
-
57749091754
-
Chromosomal rearrangements leading to MLL gene fusions: Clinical and biological aspects
-
2614694 1:CAS:528:DC%2BD1cXhsV2it7nE 19074864 doi:10.1158/0008-5472.CAN-08-2208
-
Harper DP, Aplan PD. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res. 2008;68(24):10024-7. doi:10.1158/0008-5472.CAN-08-2208.
-
(2008)
Cancer Res
, vol.68
, Issue.24
, pp. 10024-10027
-
-
Harper, D.P.1
Aplan, P.D.2
-
22
-
-
84904114990
-
MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia
-
1:CAS:528:DC%2BC2cXht1WktbrF 24695851 doi:10.1182/blood-2013-09-525741
-
Manara E, Baron E, Tregnago C, Aveic S, Bisio V, Bresolin S, et al. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia. Blood. 2014;124(2):263-72. doi:10.1182/blood-2013-09-525741.
-
(2014)
Blood
, vol.124
, Issue.2
, pp. 263-272
-
-
Manara, E.1
Baron, E.2
Tregnago, C.3
Aveic, S.4
Bisio, V.5
Bresolin, S.6
-
23
-
-
0031785825
-
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia
-
1:CAS:528:DyaK1cXmvFGrtLY%3D 9779702
-
Cortes J, Talpaz M, O'Brien S, Rios MB, Majlis A, Keating M, et al. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. J Clin Oncol. 1998;16(10):3279-85.
-
(1998)
J Clin Oncol
, vol.16
, Issue.10
, pp. 3279-3285
-
-
Cortes, J.1
Talpaz, M.2
O'Brien, S.3
Rios, M.B.4
Majlis, A.5
Keating, M.6
-
24
-
-
0012906888
-
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
-
1:CAS:528:DC%2BD3sXktVGnt7o%3D 12560227 doi:10.1182/blood-2002-09-2790
-
Cortes JE, Talpaz M, Giles F, O'Brien S, Rios MB, Shan J, et al. Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Blood. 2003;101(10):3794-800. doi:10.1182/blood-2002-09-2790.
-
(2003)
Blood
, vol.101
, Issue.10
, pp. 3794-3800
-
-
Cortes, J.E.1
Talpaz, M.2
Giles, F.3
O'Brien, S.4
Rios, M.B.5
Shan, J.6
-
25
-
-
0036720397
-
The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML
-
12176881 doi:10.1182/blood-2002-03-0777
-
O'Dwyer ME, Mauro MJ, Kurilik G, Mori M, Balleisen S, Olson S, et al. The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. Blood. 2002;100(5):1628-33. doi:10.1182/blood-2002-03-0777.
-
(2002)
Blood
, vol.100
, Issue.5
, pp. 1628-1633
-
-
O'Dwyer, M.E.1
Mauro, M.J.2
Kurilik, G.3
Mori, M.4
Balleisen, S.5
Olson, S.6
-
26
-
-
77952845388
-
Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy
-
4216809 1:CAS:528:DC%2BC3cXnvFKjtLY%3D 20499401 doi:10.1002/cncr.25015
-
Verma D, Kantarjian H, Shan J, O'Brien S, Estrov Z, Garcia-Manero G, et al. Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy. Cancer. 2010;116(11):2673-81. doi:10.1002/cncr.25015.
-
(2010)
Cancer
, vol.116
, Issue.11
, pp. 2673-2681
-
-
Verma, D.1
Kantarjian, H.2
Shan, J.3
O'Brien, S.4
Estrov, Z.5
Garcia-Manero, G.6
-
27
-
-
84255197306
-
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: Long-term observation of 1151 patients from the randomized CML Study IV
-
1:CAS:528:DC%2BC38Xjt1Clsg%3D%3D 22039253 doi:10.1182/blood-2011-08-373902
-
Fabarius A, Leitner A, Hochhaus A, Muller MC, Hanfstein B, Haferlach C, et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood. 2011;118(26):6760-8. doi:10.1182/blood-2011-08-373902.
-
(2011)
Blood
, vol.118
, Issue.26
, pp. 6760-6768
-
-
Fabarius, A.1
Leitner, A.2
Hochhaus, A.3
Muller, M.C.4
Hanfstein, B.5
Haferlach, C.6
-
28
-
-
84881298446
-
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
-
1:CAS:528:DC%2BC3sXhtlWltLbP 23803709 doi:10.1182/blood-2013-05-501569
-
Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122(6):872-84. doi:10.1182/blood-2013-05-501569.
-
(2013)
Blood
, vol.122
, Issue.6
, pp. 872-884
-
-
Baccarani, M.1
Deininger, M.W.2
Rosti, G.3
Hochhaus, A.4
Soverini, S.5
Apperley, J.F.6
-
29
-
-
0036797499
-
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias
-
1:CAS:528:DC%2BD38XovFKku7k%3D 12368154
-
Giugliano E, Rege-Cambrin G, Scaravaglio P, Wlodarska I, Emanuel B, Stul M, et al. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Haematologica. 2002;87(10):1014-20.
-
(2002)
Haematologica
, vol.87
, Issue.10
, pp. 1014-1020
-
-
Giugliano, E.1
Rege-Cambrin, G.2
Scaravaglio, P.3
Wlodarska, I.4
Emanuel, B.5
Stul, M.6
-
30
-
-
3242766715
-
Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: Results in 378 adult patients
-
1:CAS:528:DC%2BD2cXmvF2htLo%3D 15323147 doi:10.1309/RX27-R8GJ-QM33-0C22
-
Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L, et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol. 2004;122(2):298-306. doi:10.1309/RX27-R8GJ-QM33-0C22.
-
(2004)
Am J Clin Pathol
, vol.122
, Issue.2
, pp. 298-306
-
-
Cox, M.C.1
Panetta, P.2
Lo-Coco, F.3
Del Poeta, G.4
Venditti, A.5
Maurillo, L.6
-
31
-
-
81555228391
-
Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia
-
3217360 1:CAS:528:DC%2BC3MXhsFyqtrzP 21917756 doi:10.1182/blood-2011-04-348052
-
Kornblau SM, Qiu YH, Zhang N, Singh N, Faderl S, Ferrajoli A, et al. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood. 2011;118(20):5604-12. doi:10.1182/blood-2011-04-348052.
-
(2011)
Blood
, vol.118
, Issue.20
, pp. 5604-5612
-
-
Kornblau, S.M.1
Qiu, Y.H.2
Zhang, N.3
Singh, N.4
Faderl, S.5
Ferrajoli, A.6
-
32
-
-
0026215673
-
The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24
-
1:CAS:528:DyaK38Xhs1Ghsg%3D%3D 1765382
-
Baud V, Lipinski M, Rassart E, Poliquin L, Bergeron D. The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24. Genomics. 1991;11(1):223-4.
-
(1991)
Genomics
, vol.11
, Issue.1
, pp. 223-224
-
-
Baud, V.1
Lipinski, M.2
Rassart, E.3
Poliquin, L.4
Bergeron, D.5
-
33
-
-
8644286697
-
Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib
-
1:CAS:528:DC%2BD2cXovFGgt7c%3D 15512807 doi:10.1080/10428190410001723278
-
Loriaux M, Deininger M. Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib. Leuk Lymphoma. 2004;45(11):2197-203. doi:10.1080/10428190410001723278.
-
(2004)
Leuk Lymphoma
, vol.45
, Issue.11
, pp. 2197-2203
-
-
Loriaux, M.1
Deininger, M.2
-
34
-
-
35548971639
-
Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase
-
1:CAS:528:DC%2BD2sXht1Smu7%2FP 17625066 doi:10.1182/blood-2007-01-070045
-
Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S, et al. Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood. 2007;110(8):2991-5. doi:10.1182/blood-2007-01-070045.
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2991-2995
-
-
Jabbour, E.1
Kantarjian, H.M.2
Abruzzo, L.V.3
O'Brien, S.4
Garcia-Manero, G.5
Verstovsek, S.6
-
35
-
-
33750615550
-
Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia
-
1:CAS:528:DC%2BD28XhtFWgtL3N 16809614 doi:10.1182/blood-2006-04-017400
-
Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood. 2006;108(8):2811-3. doi:10.1182/blood-2006-04-017400.
-
(2006)
Blood
, vol.108
, Issue.8
, pp. 2811-2813
-
-
Kovitz, C.1
Kantarjian, H.2
Garcia-Manero, G.3
Abruzzo, L.V.4
Cortes, J.5
-
36
-
-
33744976091
-
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate
-
Perel JM, McCarthy C, Walker O, Irving I, Williams B, Kennedy GA. Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica. 2005;90 Suppl:ECR25.
-
(2005)
Haematologica
, vol.90
-
-
Perel, J.M.1
McCarthy, C.2
Walker, O.3
Irving, I.4
Williams, B.5
Kennedy, G.A.6
-
37
-
-
15044341318
-
Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha
-
1:CAS:528:DC%2BD2MXhsFOrurY%3D 15625554 doi:10.1038/sj.leu.2403607
-
Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia. 2005;19(3):460-3. doi:10.1038/sj.leu.2403607.
-
(2005)
Leukemia
, vol.19
, Issue.3
, pp. 460-463
-
-
Bacher, U.1
Hochhaus, A.2
Berger, U.3
Hiddemann, W.4
Hehlmann, R.5
Haferlach, T.6
-
38
-
-
0036051772
-
Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8
-
1:CAS:528:DC%2BD38XkvFKrt7w%3D 12094265 doi:10.1038/sj.leu.2402634
-
Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Brondum-Nielsen K. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia. 2002;16(7):1390-3. doi:10.1038/sj.leu.2402634.
-
(2002)
Leukemia
, vol.16
, Issue.7
, pp. 1390-1393
-
-
Andersen, M.K.1
Pedersen-Bjergaard, J.2
Kjeldsen, L.3
Dufva, I.H.4
Brondum-Nielsen, K.5
-
39
-
-
0037352241
-
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
-
1:STN:280:DC%2BD3s7jt1GjtQ%3D%3D 12646955 doi:10.1038/sj.leu.2402842
-
Chee YL, Vickers MA, Stevenson D, Holyoake TL, Culligan DJ. Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia. 2003;17(3):634-5. doi:10.1038/sj.leu.2402842.
-
(2003)
Leukemia
, vol.17
, Issue.3
, pp. 634-635
-
-
Chee, Y.L.1
Vickers, M.A.2
Stevenson, D.3
Holyoake, T.L.4
Culligan, D.J.5
-
40
-
-
35549009764
-
Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy
-
1:CAS:528:DC%2BD2sXht1WgsbbO 17690707 doi:10.1038/sj.leu.2404865
-
Quintas-Cardama A, Kantarjian H, Abruzzo LV, Cortes J. Extramedullary BCR-ABL1-negative myeloid leukemia in a patient with chronic myeloid leukemia and synchronous cytogenetic abnormalities in Philadelphia-positive and -negative clones during imatinib therapy. Leukemia. 2007;21(11):2394-6. doi:10.1038/sj.leu.2404865.
-
(2007)
Leukemia
, vol.21
, Issue.11
, pp. 2394-2396
-
-
Quintas-Cardama, A.1
Kantarjian, H.2
Abruzzo, L.V.3
Cortes, J.4
-
41
-
-
77954977940
-
Chronic myeloid leukemia: Mechanisms of blastic transformation
-
2898591 1:CAS:528:DC%2BC3cXovFarsLk%3D 20592475 doi:10.1172/JCI41246
-
Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254-64. doi:10.1172/JCI41246.
-
(2010)
J Clin Invest
, vol.120
, Issue.7
, pp. 2254-2264
-
-
Perrotti, D.1
Jamieson, C.2
Goldman, J.3
Skorski, T.4
-
42
-
-
80051594098
-
De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: A case study and review of the literature
-
21846973 doi:10.1159/000329389
-
Lee SG, Park TS, Oh SH, Park JC, Yang YJ, Marschalek R, et al. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature. Acta Haematol. 2011;126(4):195-8. doi:10.1159/000329389.
-
(2011)
Acta Haematol
, vol.126
, Issue.4
, pp. 195-198
-
-
Lee, S.G.1
Park, T.S.2
Oh, S.H.3
Park, J.C.4
Yang, Y.J.5
Marschalek, R.6
|